The Complexity of Weak Rhesus Positivity in Pregnancy: Challenges and Management-A Case Report

Determining a mother's Rhesus (Rh) antigen status is a critical component of prenatal care, guiding the administration of Rh immunoglobulin (RhIG) to prevent Rh alloimmunization, a condition that can lead to hemolytic disease of the newborn. Hemolytic disease of the newborn is a blood disorder where the blood types of a mother and fetus are incompatible and causes hemolysis of the fetus' erythrocytes, a major cause of fetal death. Rh immunoglobulin is commonly administered to Rh-negative (Rh-) women as a prophylactic measure. However, categorizing a patient's Rh status is not always straightforward as individuals can exhibit weakly Rh+ or formerly Rh+ phenotypes, complicating clinical management.

We present a case of a 28-year-old gravida three para two woman whose Rh status has varied across multiple pregnancies, who presented to the emergency department (ED) with an active first trimester miscarriage requesting a dose of RhIG. Her blood typing indicated O+ status, which conflicted with her previous history of O-.

Most women in the United States are Rh+, which eliminates the need for RhIG during pregnancy. Nevertheless, approximately 550,000 women annually are categorized as Rh-, and 16,700 of these cases may represent weak Rh positivity. Identifying weakly Rh+ individuals holds potential to reallocate scarce RhIG resources to those who require them. In this report we explore the clinical implications of weak Rh positivity, emphasizing maternal-fetal health considerations and the nuanced approach required to manage such cases effectively in the ED.